Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001159036-25-000017
Filing Date
2025-03-18
Accepted
2025-03-18 16:14:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxyadditional2025.htm DEFA14A 11761
2 GRAPHIC proxyadditional1.jpg GRAPHIC 139230
3 GRAPHIC proxyadditional2.jpg GRAPHIC 88148
  Complete submission text file 0001159036-25-000017.txt   325706
Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32335 | Film No.: 25748485
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)